ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69

August 12, 1988

NCI To Offer Planning Grants for New Centers

November 9, 1990

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

March 23, 2001

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

ACS Awards Professorships To Brugge, Hanahan, Samson; Renews Verma, Wigler.

February 9, 2001